Xu C - Search Results

1

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries.

Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, van den Bogaerdt A, Bogers AJ, Dirven C, Danser AJ, Xu C, Snellman J, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Among authors: xu c. Cephalalgia. 2019 Dec;39(14):1735-1744. doi: 10.1177/0333102419863027. Epub 2019 Jul 8. Cephalalgia. 2019. PMID: 31284729

2

Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine.

Bussiere JL, Davies R, Dean C, Xu C, Kim KH, Vargas HM, Chellman GJ, Balasubramanian G, Rubio-Beltran E, MaassenVanDenBrink A, Monticello TM. Bussiere JL, et al. Among authors: xu c. Regul Toxicol Pharmacol. 2019 Aug;106:224-238. doi: 10.1016/j.yrtph.2019.05.013. Epub 2019 May 11. Regul Toxicol Pharmacol. 2019. PMID: 31085251 Free article. Review.

3

Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.

Ohlsson L, Haanes KA, Kronvall E, Xu C, Snellman J, Edvinsson L. Ohlsson L, et al. Among authors: xu c. Cephalalgia. 2019 Dec;39(14):1745-1752. doi: 10.1177/0333102419867282. Epub 2019 Jul 31. Cephalalgia. 2019. PMID: 31366221

4

Assessing migraine therapeutics.

Xu C, Bussiere J. Xu C, et al. Cephalalgia. 2021 Nov;41(13):1402-1403. doi: 10.1177/03331024211021569. Epub 2021 Jun 30. Cephalalgia. 2021. PMID: 34190614 No abstract available.

5

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

Silberstein S, Lenz R, Xu C. Silberstein S, et al. Among authors: xu c. Headache. 2015 Sep;55(8):1171-82. doi: 10.1111/head.12642. Epub 2015 Aug 28. Headache. 2015. PMID: 26316307 Review.

6

Effects of monoclonal antagonist antibodies on calcitonin gene-related peptide receptor function and trafficking.

Manoukian R, Sun H, Miller S, Shi D, Chan B, Xu C. Manoukian R, et al. Among authors: xu c. J Headache Pain. 2019 Apr 30;20(1):44. doi: 10.1186/s10194-019-0992-1. J Headache Pain. 2019. PMID: 31039731 Free PMC article.

7

Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab).

Garces F, Mohr C, Zhang L, Huang CS, Chen Q, King C, Xu C, Wang Z. Garces F, et al. Among authors: xu c. Cell Rep. 2020 Feb 11;30(6):1714-1723.e6. doi: 10.1016/j.celrep.2020.01.029. Cell Rep. 2020. PMID: 32049005 Free article.

8

Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor.

Shi L, Lehto SG, Zhu DX, Sun H, Zhang J, Smith BP, Immke DC, Wild KD, Xu C. Shi L, et al. Among authors: xu c. J Pharmacol Exp Ther. 2016 Jan;356(1):223-31. doi: 10.1124/jpet.115.227793. Epub 2015 Nov 11. J Pharmacol Exp Ther. 2016. PMID: 26559125

9

The tortuous road to an ideal CGRP function blocker for the treatment of migraine.

Davis CD, Xu C. Davis CD, et al. Among authors: xu c. Curr Top Med Chem. 2008;8(16):1468-79. doi: 10.2174/156802608786264218. Curr Top Med Chem. 2008. PMID: 18991732 Review.

10

PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater.

Hensley K, Pretorius J, Chan B, Page K, Liu H, Choi C, Shi D, Xu C, Edvinsson L, Miller S. Hensley K, et al. Among authors: xu c. Cephalalgia. 2019 Jun;39(7):827-840. doi: 10.1177/0333102418821621. Epub 2018 Dec 24. Cephalalgia. 2019. PMID: 30582714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,417 results

Search Page

Filters